Campbell & CO Investment Adviser LLC Codexis, Inc. Transaction History

Campbell & CO Investment Adviser LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.26 - $6.84 $27,881 - $44,767	-6,545 Reduced 19.41%	27,175 $126,000
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $204,343 - $433,639	33,720 New	33,720 $204,000
Q1 2020 Apr 29, 2020	SELL	$8.78 - $18.6 $186,592 - $395,287	-21,252 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$13.12 - $17.06 $278,826 - $362,559	21,252 New	21,252 $340,000
Q1 2019 May 10, 2019	SELL	$15.53 - $22.15 $181,949 - $259,509	-11,716 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$14.06 - $22.57 $164,726 - $264,430	11,716 New	11,716 $217,000
Q3 2018 Nov 08, 2018	SELL	$13.35 - $19.1 $135,729 - $194,189	-10,167 Closed	0 $0
Q2 2018 Jul 13, 2018	BUY	$10.35 - $16.45 $105,228 - $167,247	10,167 New	10,167 $146,000

144

60.6M

68.5K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $167M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.